Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade
Sign Up to like & getrecommendations! Published in 2024 at "Cancer"
DOI: 10.1002/cncr.35179
Abstract: Programmed death 1 (PD‐1)/programmed death ligand 1 (PD‐L1) blockade has changed the landscape of treatment for metastatic urothelial cancer, but single‐agent cytotoxic T‐lymphocyte–associated protein 4 (CTLA‐4) blockade in metastatic urothelial cancer has been underexplored. A… read more here.
Keywords: urothelial cancer; metastatic urothelial; programmed death; death programmed ... See more keywords
Programmed Cell Death‐1 and Programmed Cell Death Ligand‐1 in Childhood Acute B‐Lymphoblastic Leukemia: Expression and Significance as Biomarker
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.14472
Abstract: This study aimed to assess programmed death‐1 (PD‐1) and programmed death ligand‐1 (PDL‐1) expression in newly diagnosed pediatric cases of acute B‐lymphoblastic leukemia (B‐ALL) and at 6 months of treatment and to explore their value as… read more here.
Keywords: programmed cell; death ligand; death programmed; cell death ... See more keywords
Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220964903
Abstract: Background Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PDL-1) inhibitors have improved survival over chemotherapy in advanced Non- Small Cell Lung Cancer (NSCLC). However, it is unclear if there are class specific differences in the… read more here.
Keywords: chemotherapy; death; death programmed; efficacy ... See more keywords
Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.645170
Abstract: Background Programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors have provided clinical benefit to head and neck squamous cell carcinoma (HNSCC) patients in recent clinical trials. However, it remains unclear as to whether human papillomavirus (HPV) status… read more here.
Keywords: status; death; death programmed; programmed death ... See more keywords